Healthcare Pharmaceutical Biotech

Patient Safety Movement Foundation Appoints Three Distinguished Leaders to Governance Board

May 28, 2026 8:45 AM

The Patient Safety Movement Foundation (PSMF) today announced the appointment of three distinguished global leaders to its Governance Board: Rt. Hon. Sir Jeremy Hunt, MP, who served as the United Kingdom's Chancellor of the Exchequer from 2022 to 2024, and a former Minister of Health; Prof. Dr. Klaus Markstaller, Medical Director and Chairman of the Executive Board at the University Hospital of Augsburg; and Margaret-Mary Wilson, MD, Executive...

Read more

TRNR Updates Investor Presentation Detailing Acquisition Strategy and Increased M&A Pipeline

May 28, 2026 8:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today published an updated investor presentation detailing its acquisition-driven operating strategy, the contribution of recently completed acquisitions, and an increased M&A pipeline. The updated presentation reflects the Company's transformation through the Wattbike and Ergatta...

Read more

Aspire Biopharma Issues Shareholder Letter

May 28, 2026 8:30 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today issued the following letter to shareholders from Chief Executive Officer Kraig Higginson. Dear Fellow Shareholders, 2026 is shaping up to be a defining year for Aspire Biopharma Holdings. We are moving with speed to transform our clinical pipeline into commercial reality,...

Read more

Black Book to Release 2026 Top Vendor Client Satisfaction Results Ahead of AHIP26 and HFMA Annual Conferences

May 28, 2026 8:10 AM

Black Book Research today announced that it will release two major waves of 2026 client satisfaction results next week, ahead of two of healthcare's most important executive conferences: AHIP26, scheduled for June 9-10, 2026, at Wynn Las Vegas, and HFMA's Annual Conference, scheduled for June 7-10, 2026, in National Harbor, Maryland. The forthcoming Black Book announcements will recognize top-performing vendors in 60 payer IT functions, based on...

Read more

Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer

May 28, 2026 8:05 AM

Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced the appointment of Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer. Dr. Janatpour brings more than 25 years of oncology research and development leadership across biotechnology and pharmaceutical...

Read more

Phase 1 Equity Announces Its Third Practice Addition of the Year, Bringing on a Multi-Site Orthodontic Practice Located in Texas

May 28, 2026 8:00 AM

Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome another leading multi-site orthodontic practice based in Texas to its growing network. This practice ensures each patient feels welcomed and is treated in a comfortable, kind, and family-friendly environment. They offer highly personalized care, backed by advanced orthodontic techniques and driven expertise....

Read more

Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock

May 28, 2026 7:40 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that holders of a 1,333,930 common shares, representing a majority of the outstanding common shares of the Company, have entered into a lock-up agreement that precludes the sale of their shares into the market for at least 90 days. "This...

Read more

Protagonist Therapeutics to Participate in Two Investment Bank Conferences in June 2026

May 28, 2026 7:05 AM

Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in two investment bank conferences taking place in June 2026. 2026 Jefferies Global Healthcare Conference; New York, NY - June 2-4, 2026 Format: Fireside Chat Day/Time: Wednesday, June 3 at 9:55 A.M. ET Webcast:...

Read more

Dr. David Pincus of Pincus Plastic Surgery Educates Patients on Choosing Between Implants and Fat Transfer for Breast Enhancement

May 28, 2026 6:55 AM

Board-certified plastic surgeon Dr. David Pincus is helping patients better understand their options for breast enhancement by providing clear guidance on two widely discussed approaches: breast implants and fat transfer. Through patient education, individualized consultations, and a patient-first philosophy, Dr. Pincus continues to ensure that every treatment plan reflects the patient's goals, anatomy, comfort level, and long-term expectations....

Read more

Applications are Open for the 2026 Semmelweis-Richter Journalism Award Until June 9th

May 28, 2026 3:00 AM

After the strong success of its first edition, the Semmelweis-Richter Journalism Award returns in 2026. Journalists from eligible European countries are invited to submit entries in two categories: Women's Health and Pharmaceutical Strategies and Innovation, with a special focus on cardiovascular therapies. The application deadline is June 9, 2026, 23:59 CET. The international award was first launched in 2025 by Semmelweis University, Hungary's...

Read more

Wellgistics Health Refinances Outstanding Convertible Debt and Raises $6.5M

May 27, 2026 5:50 PM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it completed a financing transaction through the issuance of a new $21 million convertible debt instrument (the "New Debt") that refinances all of its outstanding convertible debt and provides $6.5 million in fresh capital (the "New...

Read more

Siemens Healthineers and Cercare Medical Announce Global Collaboration on Cone-Beam CT Perfusion Guided Stroke Treatment

May 27, 2026 1:05 PM

Cercare Medical and Siemens Healthineers today announced a global collaboration to accelerate the adoption of Cone-Beam CT Perfusion (CBCT-P) in acute stroke care and leverage its capability to show the flow of blood through the brain's tissue and visualize how well different areas are being supplied with oxygen and nutrients. The joint solution combines the Cercare Medical Neurosuite (CMN), an integrated portfolio of advanced, vendor-neutral...

Read more

Myriad Systems(TM) Named 'Best Compliance Management Solution Provider' in 2026 MedTech Breakthrough Awards Program

May 27, 2026 9:10 AM

Myriad Systems, a leader in healthcare technology, today announced it has been selected as the winner of the "Best Compliance Management Solution Provider" award in the 10th annual MedTech Breakthrough Awards program. The award recognizes Myriad Health's MyScribe AI and was presented by MedTech Breakthrough, an independent market intelligence firm focused on digital health and medical technology innovation. Myriad Systems' broader healthcare...

Read more

Aetna Better Health of Missouri Collaborates With Local Organizations To Address Food Insecurity and Enhance Safety and Wellness Supports

May 27, 2026 9:00 AM

Aetna Better Health of Missouri, a CVS Health company (NYSE:CVS), announced that Aetna has committed $175,000 to support two local organizations working to help families in southern Missouri and the Kansas City and St. Louis areas. The funding will expand access to nutritious foods, strengthen farm sustainability and enhance safety and wellness supports, such as a women's shelter and diaper bank. "Food insecurity is one of the most significant...

Read more

Jaguar Health Compliant with Nasdaq Bid Price Rule

May 27, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that on May 26, 2026, the Company received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") that Jaguar has regained compliance with Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule"). "We are very happy that Jaguar has regained compliance with the Nasdaq listing criteria. We consider our Nasdaq listing an asset of the Company," said Lisa Conte, Jaguar's...

Read more

Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members

May 27, 2026 8:30 AM

Aspire Biopharma Holdings, Inc.'s (Nasdaq:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC is proud to announce a strategic partnership with EoS Fitness, the High Value. Low Price.® (HVLP) gym chain with more than 225 locations open or on the way nationwide. Through the EoS Flex Deals affiliate program, BUZZ BOMB™ 's lineup of 50mg sublingual caffeine stick packs will now be available to an expansive...

Read more

Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Investment by Niowave at Closing

May 27, 2026 8:05 AM

Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, and Niowave, Inc., a leader in radioisotope production and supply with established partnerships across the radiopharmaceutical ecosystem, today announced a 50/50 strategic collaboration to develop up to three radiopharmaceutical...

Read more

MIRA Pharmaceuticals Secures Worldwide Rights for Ketamir-2, Expanding Global IP Portfolio Across 10 Major Markets Ahead of Phase 2a in CIPN

May 27, 2026 8:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company focused on the development of proprietary therapeutics for neurologic, neuropsychiatric, inflammatory, and metabolic disorders, today announced the execution of Amendment No. 1 to its exclusive Ketamir-2 license agreement with MIRALOGX LLC, expanding the Company's licensed territory from the United States, Canada, and Mexico to worldwide...

Read more

Botox Certification for Nurses

May 27, 2026 6:00 AM

As the cosmetic injectables market continues to expand across the United States, registered nurses and nurse practitioners are increasingly turning to accredited certification programs to enter the field of aesthetic medicine. Among available options, the American Academy of Cosmetic Medicine® (AACM™) is recognized as one of the leading choices for nurses seeking online Botox certification at an affordable price of $199 plus taxes. What Makes...

Read more

Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference

May 27, 2026 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will be presenting at the 2026 Jefferies Healthcare Conference on Wednesday, June 3, 2026, at 4:55 p.m. ET. For access to the webcast, visit Amphastar Pharmaceuticals' website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation. About Amphastar Pharmaceuticals,...

Read more